Ambr15 Generation 2 optional accessories and consumables

This event has concluded. *Please note that there are currently no plans for on-demand distribution. mRNA pharmaceuticals are attracting attention as a new modality for drug discovery. Sartorius has a wide range of technologies that cover the mRNA manufacturing process, including E. coli culture, pDNA purification, IVT reactions, mRNA purification, and freeze storage. In this forum, we will provide a meaningful discussion platform centered around topics such as "pDNA|mRNA Manufacturing Processes," "Sartorius Manufacturing Platforms," and "Application Examples," inviting guest speakers to give presentations and facilitating questions and interactions from participants. Special Lecture Kazuhisa Uchida, Graduate School, Kobe University Capacity [In-person participation] 35 people *If there are many applications, a lottery will be held. [Online participation] 200 people *Please note that applications from competitors and research companies may be declined in advance.

Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. The Ambr 15 is an industry-standard microbioreactor system that can perform with 10-15 mL of culture medium in 24 or 48 parallel runs. After culturing, there was a challenge where the number of samples for clarification and simple purification matched the number of specimens, which became a rate-limiting step. However, the next-stage robotic device, StreamLink CC 15, from Ambr has emerged as a breakthrough. This webinar will introduce the advantages of this product, focusing on throughput, in two parts. 【Seminar Overview】 June 1, 2023 (Thursday) from 15:00 (approximately 40 minutes) Webinar recorded broadcast [Japanese, Free] *We sincerely apologize, but participation from companies in the same industry and email addresses other than those of your organization is not permitted. Thank you for your understanding.

Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. The development of therapeutics using viral vectors is showing strong activity, with over 30% market growth expected in the next decade. The targets for treatment are diverse, but identifying critical process parameters through process development has become an urgent issue. As the first of two webinars, we will introduce the Ambr series, a representative of process development systems in upstream processes, as well as single-use bag bioreactors up to 2000L for large-scale manufacturing, including examples of associated PAT products. *We sincerely apologize, but participation from email addresses other than those of your company or organization is not permitted. Thank you for your understanding.

The reception here has ended. Thank you for your registration. A must-see for those looking for solutions to the complex process development of gene therapy! The field of gene therapy has been receiving increasing attention in recent years, but its long and complex processes involve many considerations, requiring significant time and effort for optimization. At JAACT2022, our specialists will introduce solutions focused on process development using HEK293 cells. In the technical seminar at the venue, we will propose the latest technologies and solutions, including new products. Additionally, at our booth, we will showcase Sartorius's new products (HEK293 media sample kit | Ambr 250 perfusion) and hold demonstrations (MODDE | SIMCA). Technical Seminar Information Title: Challenges in New Modalities by Sartorius Date and Time: July 26 (Wednesday) 15:10 - 15:35 [Main Learning Content] ▪ Case study using microreactor systems (Ambr) ▪ Tools that can be used for scale-up ▪ HEK293 cell culture media system